OVERTURE:一项全球性、前瞻性、观察性研究,探讨常染色体显性多囊肾病患者的疾病特征
OVERTURE研究前瞻性纳入3409例常染色体显性多囊肾病(ADPKD)患者,覆盖12-78岁、CKD G1-G5期及Mayo影像分类1A-1E。结果显示,磁共振成像(MRI)测得的身高校正总肾脏体积(htTKV)每增加1 l/m,与估算肾小球滤过率(eGFR)更低、高血压、肾痛、血尿、健康相关生活质量更差、工作生产力下降及医疗资源利用增加相关。结论指出肾脏体积对肾功能以外的结局具有预测价值,但随访最长仅3年。
要点
- htTKV每增加1 l/m与eGFR更低相关(回归系数17.02,95%CI 15.94-18.11)。
- htTKV每增加1 l/m与高血压(OR 1.25)、肾痛(OR 1.22)、血尿(OR 1.35)风险更高相关。
- htTKV较高与健康相关生活质量更差、工作生产力下降及医疗资源利用增加相关。
核心结论
- 尽管受限于最长3年的随访时间,该观察性研究描述了广泛人群中ADPKD的疾病负担,并表明肾脏体积对肾功能以外的结局具有预测价值。
研究设计与样本
- 前瞻性、观察性、纵向研究(OVERTURE;NCT01430494),纳入国际大型人群(N=3409),覆盖12-78岁、CKD G1-G5期及Mayo影像分类1A-1E。
- 结局包括肾功能、并发症、生活质量、医疗资源利用和工作生产力。
主要发现
- 多数受试者(84.4%)完成至少12个月随访。
- MRI测得htTKV每增加1 l/m,与eGFR更低相关(回归系数17.02,95%CI 15.94-18.11)。
- htTKV每增加1 l/m,与高血压可能性更高相关(OR 1.25,95%CI 1.17-1.34)。
- htTKV每增加1 l/m,与肾痛可能性更高相关(OR 1.22,95%CI 1.11-1.33)。
- htTKV每增加1 l/m,与血尿可能性更高相关(OR 1.35,95%CI 1.21-1.51)。
关键数值与推荐
- 基线htTKV较高与ADPKD影响量表身体评分更差相关(回归系数1.02,95%CI 0.65-1.39)。
- 基线htTKV较高与工作天数缺失更多相关(回归系数0.55,95%CI 0.18-0.92)。
- 基线htTKV较高与住院可能性更高相关(OR 1.48,95%CI 1.33-1.64)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 随访时间最长3年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The course of autosomal dominant polycystic kidney disease (ADPKD) varies greatly among affected individuals, necessitating natural history studies to characterize the determinants and effects of disease progression. Therefore, we conducted an observational, longitudinal study (OVERTURE; NCT01430494) of patients with ADPKD. METHODS: This prospective study enrolled a large international population (N = 3409) encompassing a broad spectrum of ages (12-78 years), chronic kidney disease (CKD) stages (G1-G5), and Mayo imaging classifications (1A-1E). Outcomes included kidney function, complications, quality of life, health care resource utilization, and work productivity. RESULTS: Most subjects (84.4%) completed ≥12 months of follow-up. Consistent with earlier findings, each additional l/m of height-adjusted total kidney volume (htTKV) on magnetic resonance imaging (MRI) was associated with worse outcomes, including lower estimated glomerular filtration rate (eGFR) (regression coefficient 17.02, 95% confidence interval [CI] 15.94-18.11) and greater likelihood of hypertension (odds ratio [OR] 1.25, 95% CI 1.17-1.34), kidney pain (OR 1.22, 95% CI 1.11-1.33), and hematuria (OR 1.35, 95% CI 1.21-1.51). Greater baseline htTKV was also associated with worse patient-reported health-related quality of life (e.g., ADPKD Impact Scale physical score, regression coefficient 1.02, 95% CI 0.65-1.39), decreased work productivity (e.g., work days missed, regression coefficient 0.55, 95% CI 0.18-0.92), and increased health care resource utilization (e.g., hospitalizations, OR 1.48, 95% CI 1.33-1.64) during follow-up. CONCLUSION: Although limited by a maximum 3-year duration of follow-up, this observational study characterized the burden of ADPKD in a broad population and indicated the predictive value of kidney volume for outcomes other than kidney function.
引用
- Perrone RD, Oberdhan D, Ouyang J, et al. OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD. Kidney Int Rep. 2023. PMID: 37180499. doi:10.1016/j.ekir.2023.02.1073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。